BioRestorative Therapies Inc (BRTX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:BioRestorative Therapies Inc (BRTX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7877
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment for chronic lumbar disc diseases such as bulging and herniated discs. Its ThermoStem program develops brown fat stem cell-based therapy which is used for the treatment of type 2 diabetes, obesity, and other metabolic disorders. BRT provides identification and treatment of first stem cell population isolated from a particular brown fat depot in humans. The company operates in the US. BRT is headquartered in Melville, New York, the US.

BioRestorative Therapies Inc (BRTX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioRestorative Therapies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioRestorative Therapies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
BioRestorative Therapies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioRestorative Therapies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
BioRestorative Therapies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BioRestorative Therapies Inc, Medical Equipment, Deal Details 10
BioRestorative Therapies Enters Into Licensing Agreement With Regenerative Sciences For Stem Cell Disc And Spine Procedure 10
Equity Offering 11
BioRestorative Therapies Files Registration Statement for Public Offering of Shares and Warrants for up to USD15 Million 11
Debt Offering 12
BioRestorative Therapies Raises USD0.2 Million in Private Placement of 8% Note Due 2017 12
BioRestorative Therapies Raises USD0.24 Million in Private Placement of 8% Note Due 2017 13
BioRestorative Therapies Raises USD0.21 Million in Private Placement of 8% Note Due 2017 14
BioRestorative Therapies Inc – Key Competitors 15
BioRestorative Therapies Inc – Key Employees 16
BioRestorative Therapies Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
Jul 25, 2018: BioRestorative Therapies Appoints Jason M. Lipetz to its Scientific Advisory Board 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
BioRestorative Therapies Inc, Medical Equipment, Key Facts, 2017 2
BioRestorative Therapies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
BioRestorative Therapies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioRestorative Therapies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
BioRestorative Therapies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioRestorative Therapies Inc, Deals By Market, 2012 to YTD 2018 8
BioRestorative Therapies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BioRestorative Therapies Enters Into Licensing Agreement With Regenerative Sciences For Stem Cell Disc And Spine Procedure 10
BioRestorative Therapies Files Registration Statement for Public Offering of Shares and Warrants for up to USD15 Million 11
BioRestorative Therapies Raises USD0.2 Million in Private Placement of 8% Note Due 2017 12
BioRestorative Therapies Raises USD0.24 Million in Private Placement of 8% Note Due 2017 13
BioRestorative Therapies Raises USD0.21 Million in Private Placement of 8% Note Due 2017 14
BioRestorative Therapies Inc, Key Competitors 15
BioRestorative Therapies Inc, Key Employees 16
BioRestorative Therapies Inc, Subsidiaries 17

List of Figures
BioRestorative Therapies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
BioRestorative Therapies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
BioRestorative Therapies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
BioRestorative Therapies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
BioRestorative Therapies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioRestorative Therapies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
BioRestorative Therapies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioRestorative Therapies Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[BioRestorative Therapies Inc (BRTX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Syneron Medical Ltd-医療機器分野:企業M&A・提携分析
    Summary Syneron Medical Ltd (Syneron) is an aesthetic medical device company. It designs, develops and markets aesthetic medical products. The company products target a range of non-invasive aesthetic medical procedures and address wide range of cosmetic and medical indications such as treatment of …
  • Grant Thornton International Ltd:企業の戦略的SWOT分析
    Grant Thornton International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Factor Therapeutics Ltd (FTT)-医療機器分野:企業M&A・提携分析
    Summary Factor Therapeutics Ltd (FTL), formerly Tissue Therapies Ltd is a developer of wound care therapeutics. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. Its lead therapeutic candidate, VF-001 is a targeted growth factor w …
  • Sheraton Seoul Palace:企業の戦略・SWOT・財務分析
    Sheraton Seoul Palace - Strategy, SWOT and Corporate Finance Report Summary Sheraton Seoul Palace - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Falck Renewables SpA (FKR):企業の財務・戦略的SWOT分析
    Falck Renewables SpA (FKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Grupo SATA:企業の戦略的SWOT分析
    Grupo SATA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Conn’S, Inc.
    Conn'S, Inc. - Strategy, SWOT and Corporate Finance Report Summary Conn'S, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Carl Zeiss Meditec Inc.:医療機器:M&Aディール及び事業提携情報
    Summary Carl Zeiss Meditec Inc (Carl Zeiss Meditec), a subsidiary of Carl Zeiss Meditec AG is a medical technology company that manufactures and markets various healthcare products. The company provides ophthalmology and optometry products, neurosurgery products, ENT products, spine surgery products …
  • Aliancys AG:企業の戦略的SWOT分析
    Aliancys AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Mtr Corporation Ltd
    Mtr Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Mtr Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Wesfarmers Limited:戦略・SWOT・企業財務分析
    Wesfarmers Limited - Strategy, SWOT and Corporate Finance Report Summary Wesfarmers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Treeway BV-製薬・医療分野:企業M&A・提携分析
    Summary Treeway BV (Treeway) is a biotechnology company that develops drugs for the treatment of amyotrophic lateral sclerosis (ALS). The company’s pipeline products include TW001, TW002, TW003, and TW004. TW001 is an oral formulation of edaravone, which protects against neuronal apoptosis and oxida …
  • Mayo Foundation for Medical Education and Research:企業の戦略的SWOT分析
    Mayo Foundation for Medical Education and Research - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key compet …
  • MedSynergies Inc:医療機器:M&Aディール及び事業提携情報
    Summary MedSynergies Inc (MedSynergies), a subsidiary of Optum Inc, is a healthcare service provider that offers services in business aspects of medicine. The company offers revenue cycle management, consulting services, practice management, business process analysis and software integration solutio …
  • Parexel International Corp:企業の戦略的SWOT分析
    Parexel International Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • United States Steel Corp (X):企業の財務・戦略的SWOT分析
    United States Steel Corp (X) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Ypsomed Holding AG (YPSN)
    Ypsomed Holding AG (YPSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • PT Jasa Marga (Persero) Tbk:企業の戦略・SWOT・財務情報
    PT Jasa Marga (Persero) Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Jasa Marga (Persero) Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Chronos Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Chronos Therapeutics Ltd (Chronos) is a developer of medications for degenerative and behavioural diseases of the brain and nervous system. The company offers research and development, screening, discovery, repositioning and acquisition programs. Its pipeline products comprise RDC5 neurodege …
  • Jones Lang LaSalle Inc (JLL):企業の財務・戦略的SWOT分析
    Jones Lang LaSalle Inc (JLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆